Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. Shareholder Equity 2012–2025
Catalyst Pharmaceuticals Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Catalyst Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 954.3M, a 31.15% increase year-over-year.
- Catalyst Pharmaceuticals Inc. shareholder equity for 2025 were 954.3M, a 31.15% increase from 2024.
- Catalyst Pharmaceuticals Inc. shareholder equity for 2024 were 727.6M, a 87.59% increase from 2023.
- Catalyst Pharmaceuticals Inc. shareholder equity for 2023 were 387.9M, a 29.11% increase from 2022.
- Catalyst Pharmaceuticals Inc. shareholder equity for 2022 were 300.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Catalyst Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $954 |
| 2024 | $728 |
| 2023 | $388 |
| 2022 | $300 |
| 2021 | $207 |
| 2020 | $170 |
| 2019 | $88 |
| 2018 | $51 |
| 2017 | $81 |
| 2016 | $39 |
| 2015 | $55 |
| 2014 | $35 |
| 2013 | $21 |
| 2012 | $15 |
Catalyst Pharmaceuticals Inc. Shareholder Equity — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPRX's shareholder equity history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.